PROTEMBIS-GMBH
25.2.2021 06:17:10 CET | Business Wire | Press release
Protembis GmbH , a privately held emerging medical device company, announced today the successful completion of 20 clinical cases in its European regulatory study of the ProtEmbo® Cerebral Protection System. The ProtEmbo® System is an intra-aortic filter device that deflects embolic material away from the brain during transcatheter aortic valve replacement (TAVR). The device is a low profile system which is delivered through the left radial artery, an ideal access site enabling physicians to avoid interference with TAVR equipment, typically delivered through the left femoral artery.
Nikos Werner, M.D. , Professor of Medicine, Head of Cardiology at the Heart Center Trier, Germany, and Principal Investigator in Germany commented: “Embolic protection in TAVR procedures has been shown to be effective in reducing the ischemic burden in the brain, but physicians look forward to next generation devices that are easy to use, cover all three potential access arteries to the brain, and can be simply and rapidly deployed without interfering with the TAVR procedure. The initial procedures with the ProtEmbo® System are very promising in this regard and show that the device can fulfil all of these criteria, with even smaller pores allowing effective protection of the brain.”
This new generation of the ProtEmbo® System has an improved frame shape and a dedicated ergonomic handle to facilitate push-pull and torque of the device during deployment and retrieval. The filter, using 60 micron pores, is self-positioning in the aortic arch across all three major cerebral arteries, maintaining blood flow to the brain. The filter surface is heparin-coated to avoid clot formation.
Dariusz Jagielak, M.D. , Professor of Medicine, and his team at Medical University of Gdansk, Poland, have performed more than ten procedures with the device. He commented: “Recently, we presented the very first-in-human case at the PCR Valves e-Course in which the ProtEmbo® System was able to protect all three cerebral vessels from debris migration in a challenging TAVR procedure. Using the ProtEmbo® System is very intuitive because it is self-positioning across all three cerebral vessels and does not interfere with TAVR devices and accessories used during the procedure.”
Eberhard Grube, M.D. , Professor of Medicine, Head of Center of Innovative Interventions in Cardiology at University Hospital Bonn, Germany, Consulting Professor at Stanford University School of Medicine and Clinical Advisor to Protembis, commented: “The ProtEmbo® System has shown to be intuitively designed for seamless integration into the TAVR workflow. I am excited about this device because it offers a simple and elegant solution for reducing the risk of stroke during TAVR.”
Co-CEOs of Protembis, Conrad Rasmus and Karl von Mangoldt, are pleased with the progress of the study and commented: “We believe that the full coverage cerebral protection of the ProtEmbo® System from even extremely small particles in combination with outstanding simplicity enabling rapid and easy deployment will offer physicians significant advantages over existing technologies."
The objective of the European trial (PROTEMBO C Trial, NCT04618718 ) is to assess the safety and performance of the ProtEmbo® System used for embolic protection during TAVR compared to historical data. The trial is designed as a multi-center, single-arm study in 60 patients with severe symptomatic native aortic valve stenosis indicated for TAVR. Patients will undergo MRI assessments to evaluate the efficacy of the ProtEmbo® System.
About Protembis
Protembis is a privately-held, emerging medical device company that has developed the ProtEmbo® Cerebral Protection System. The company strives to offer a simple and reliable solution to protect patients from brain injury during left-sided heart procedures, improving patient quality of life and reducing overall healthcare costs associated with brain injury during those procedures. The ProtEmbo® System is available for investigational use only and is not approved for sale.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005838/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SES: Full Year 2025 Results2.3.2026 07:30:00 CET | Press release
SES S.A. fully consolidates Intelsat from 17 July 2025 and announces financial results for the year ended 31 December 2025 FY25 Performance (€ million) 2025 as reported (1) 2024 as reported (1) ∆ at constant FX (2) 2025 like-for-like (3) 2024 like-for-like (3) ∆ at constant FX (2) Average €/$ FX rate 1.12 1.09 1.12 1.09 Revenue (4) 2,627 2,001 +33.9% 3,512 3,656 -1.6% Adjusted EBITDA (4) (5) 1,196 1,028 +19.1% 1,529 1,783 -12.1% 1) ‘Reported basis’ with Intelsat fully consolidated from 17 July 2025 2) ‘At constant FX’ refers to comparative figures restated at the current period FX to neutralise currency variations 3) ‘Like-for-like basis’ as if Intelsat fully consolidated from 1 January 2024 4) Full-year 2025 results include the effects of purchase price accounting (PPA) related to Intelsat acquisition: Negative impact of €6m on revenue & €8m on Adj. EBITDA 5) Excluding operating expenses/income recognised in relation to U.S. C-band repurposing, other income non-recurring, fair value m
Airgain and Nextivity Enter Strategic Partnership on Co-developing Next Generation Integrated 4G / 5G Solutions2.3.2026 07:30:00 CET | Press release
Airgain, Inc. (NASDAQ: AIRG), a leading provider of wireless connectivity solutions, and Nextivity, Inc., an industry leader in intelligent cellular coverage solutions, today announced they have entered into a Strategic Partnership Agreement to collaborate on the development of integrated solutions aimed at improving 4G and 5G coverage across challenging indoor and outdoor environments. The agreement establishes a structured framework for Airgain and Nextivity to jointly define and co-develop integrated coverage solutions that leverage Airgain’s Lighthouse™ 5G Intelligent Node platform and Nextivity’s GO family of intelligent repeaters powered by Nextivity’s IntelliBoost® processor to enhance 4G and 5G coverage solutions beyond the walls of a building. Large Market Opportunity & Accelerated Go‑to‑Market Execution Industry demand for intelligent 4G and 5G coverage-extension solutions continues to accelerate as operators, enterprises, and public safety organizations expand network densif
NTT DOCOMO BUSINESS and Airlinq Form Strategic Partnership for Global IoT2.3.2026 07:00:00 CET | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation; Headquarters: Chiyoda-ku, Tokyo; President and CEO: Katsushige Kojima; “NTT DOCOMO BUSINESS”) and Airlinq Inc. (Headquarters: California, USA; CEO: Sunil Kaul; “Airlinq”), a global provider of AIoT solutions and Autonomous Connectivity Management Platform (CMP)1, have entered into a strategic partnership to expand the delivery of global IoT-connected solutions across markets with diverse and country-specific telecommunications regulatory requirements2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301475708/en/ Conceptual Overview of This Partnership 1. Background Global deployment of IoT-enabled devices and services continues to accelerate, particularly across mobility industries such as automotive and construction machinery. As connected services—including connected vehicles3—expand across borders, enterprises increasingly require reliable connectivity
PHCbi Launches LiCellGrow™ Cell Expansion System to Support High-Quality and Efficient Production of Cell and Gene Therapies2.3.2026 06:12:00 CET | Press release
— Proprietary In-Line Monitoring Technology Enables Seamless Scale-Up from Basic Research to Commercial Manufacturing — PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provider of laboratory sample storage and cell cultivation solutions and subsidiary of PHC Holdings Corporation (Head Office: Chiyoda-ku, Tokyo), today announced the launch of its new cell expansion system LiCellGrow™ (*1) for research use in Japan and other select countries worldwide(*2). The system is designed to improve quality and efficiency in the production of new advanced therapies by allowing therapy developers to visualize metabolic changes in cells in real time and automatically control culture conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301429276/en/ Controller and processor, Filter-less culture bag and reservoir/waste bags *Controller and other acce
Corning Launches Corning® Gorilla® Glass Ceramic 3 with Enhanced Drop Durability2.3.2026 06:05:00 CET | Press release
Motorola will feature the advanced cover material on its next-generation foldable device. Corning Incorporated (NYSE: GLW) today announced the launch of Corning® Gorilla® Glass Ceramic 3, the toughest Gorilla Glass Ceramic ever made. Designed to help deliver enhanced durability across a device’s lifetime, Gorilla Glass Ceramic 3 will be featured on Motorola’s upcoming razr fold device. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227039398/en/ Corning® Gorilla® Glass Ceramic 3 is the toughest Gorilla Glass Ceramic ever made. “We engineer our materials with longevity in mind, not just initial performance,” said Lori Hamilton, Division Vice President & Business Technology Director, Corning® Gorilla® Glass. “With our unparalleled expertise in glass and ceramic science, we built Gorilla Glass Ceramic 3 to provide consistent, reliable durability that holds up over time.” Consumer devices are routinely exposed to a variety of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom